University challenge: collaboration for major eye survey

Article

Anglia Ruskin University is working in collaboration with the University of the West Indies to conduct the National Eye Survey of Trinidad and Tobago (NESTT).

Anglia Ruskin University is working in collaboration with the University of the West Indies to conduct the National Eye Survey of Trinidad and Tobago (NESTT).

The survey will be Trinidad and Tobago's first major eye survey in 80 years and will initially include 7000 randomly chosen subjects. Trinidad and Tobago currently has the highest rate of diabetes in the Caribbean with almost one in five of the population affected.

Dr Khan, Trinidad and Tobago’s Minister of Health, said, "One area the Ministry of Health of Trinidad and Tobago hopes to address is the lack of data on eye health and blindness. One of the things we do know is that 70% of the eye surgeries performed in Trinidad and Tobago is for the removal of cataracts. Approximately 2500 cataract extractions per year are performed at our public hospitals, with approximately 3000 new cases being presented annually. Due to this long waiting time, up to two years in some regions, many people become blind or visually impaired due to this readily treatable condition."

Professor Bourne, Anglia Ruskin's Vision and Eye Research Unit (VERU), commented, “The purpose of NESTT is to discover where the unmet needs are within Trinidad and Tobago. Anglia Ruskin staff will be the scientific advisors for NESTT and we are currently assembling a team to work alongside the University of the West Indies."

Professor Bourne also leads an investigation, compiled by the Vision Loss Group for the World Health Organisation, entitled "Global Burden of Disease Study." He continued, "The Caribbean has very little data on this subject; in fact there hasn’t been a study in this region for about 20 years. This Trinidad and Tobago project, which will take two years to complete, should help to fill a hole of knowledge that has been exposed by the Global Burden of Disease Study.”

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.